251 related articles for article (PubMed ID: 17143275)
1. HLA-DM targets the hydrogen bond between the histidine at position beta81 and peptide to dissociate HLA-DR-peptide complexes.
Narayan K; Chou CL; Kim A; Hartman IZ; Dalai S; Khoruzhenko S; Sadegh-Nasseri S
Nat Immunol; 2007 Jan; 8(1):92-100. PubMed ID: 17143275
[TBL] [Abstract][Full Text] [Related]
2. Cutting edge: HLA-DM functions through a mechanism that does not require specific conserved hydrogen bonds in class II MHC-peptide complexes.
Zhou Z; Callaway KA; Weber DA; Jensen PE
J Immunol; 2009 Oct; 183(7):4187-91. PubMed ID: 19767569
[TBL] [Abstract][Full Text] [Related]
3. Editing of the HLA-DR-peptide repertoire by HLA-DM.
Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
[TBL] [Abstract][Full Text] [Related]
4. Influence of histidine beta81 of HLA-DR101 on peptide binding and presentation to T-cell receptor.
Figueredo Dos Santos C; Tilkin-Mariame AF; De Préval C; Lakhdar-Ghazal F
Hum Immunol; 2002 Jun; 63(6):459-66. PubMed ID: 12039521
[TBL] [Abstract][Full Text] [Related]
5. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM.
Weber DA; Evavold BD; Jensen PE
Science; 1996 Oct; 274(5287):618-20. PubMed ID: 8849454
[TBL] [Abstract][Full Text] [Related]
6. Identification of the HLA-DM/HLA-DR interface.
Davies MN; Lamikanra A; Sansom CE; Flower DR; Moss DS; Travers PJ
Mol Immunol; 2008 Feb; 45(4):1063-70. PubMed ID: 17870168
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: HLA-DM-mediated peptide exchange functions normally on MHC class II-peptide complexes that have been weakened by elimination of a conserved hydrogen bond.
Ferrante A; Gorski J
J Immunol; 2010 Feb; 184(3):1153-8. PubMed ID: 20038641
[TBL] [Abstract][Full Text] [Related]
8. Identification of the lateral interaction surfaces of human histocompatibility leukocyte antigen (HLA)-DM with HLA-DR1 by formation of tethered complexes that present enhanced HLA-DM catalysis.
Stratikos E; Mosyak L; Zaller DM; Wiley DC
J Exp Med; 2002 Jul; 196(2):173-83. PubMed ID: 12119342
[TBL] [Abstract][Full Text] [Related]
9. "Chemical analogues" of HLA-DM can induce a peptide-receptive state in HLA-DR molecules.
Marin-Esteban V; Falk K; Rötzschke O
J Biol Chem; 2004 Dec; 279(49):50684-90. PubMed ID: 15381703
[TBL] [Abstract][Full Text] [Related]
10. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules.
Kropshofer H; Vogt AB; Thery C; Armandola EA; Li BC; Moldenhauer G; Amigorena S; Hämmerling GJ
EMBO J; 1998 Jun; 17(11):2971-81. PubMed ID: 9606180
[TBL] [Abstract][Full Text] [Related]
11. Enhanced catalytic action of HLA-DM on the exchange of peptides lacking backbone hydrogen bonds between their N-terminal region and the MHC class II alpha-chain.
Stratikos E; Wiley DC; Stern LJ
J Immunol; 2004 Jan; 172(2):1109-17. PubMed ID: 14707085
[TBL] [Abstract][Full Text] [Related]
12. Disruption of hydrogen bonds between major histocompatibility complex class II and the peptide N-terminus is not sufficient to form a human leukocyte antigen-DM receptive state of major histocompatibility complex class II.
Schulze MS; Anders AK; Sethi DK; Call MJ
PLoS One; 2013; 8(7):e69228. PubMed ID: 23976922
[TBL] [Abstract][Full Text] [Related]
13. Masking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules.
Burster T; Macmillan H; Hou T; Schilling J; Truong P; Boehm BO; Zou F; Lau K; Strohman M; Schaffert S; Busch R; Mellins ED
Immunology; 2010 Jul; 130(3):436-46. PubMed ID: 20331476
[TBL] [Abstract][Full Text] [Related]
14. Interaction between HLA-DM and HLA-DR involves regions that undergo conformational changes at lysosomal pH.
Ullrich HJ; Döring K; Grüneberg U; Jähnig F; Trowsdale J; van Ham SM
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13163-8. PubMed ID: 9371817
[TBL] [Abstract][Full Text] [Related]
15. Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides.
Pashine A; Busch R; Belmares MP; Munning JN; Doebele RC; Buckingham M; Nolan GP; Mellins ED
Immunity; 2003 Aug; 19(2):183-92. PubMed ID: 12932352
[TBL] [Abstract][Full Text] [Related]
16. Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM.
Vogt AB; Kropshofer H; Moldenhauer G; Hämmerling GJ
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9724-9. PubMed ID: 8790398
[TBL] [Abstract][Full Text] [Related]
17. HLA-DM recognizes the flexible conformation of major histocompatibility complex class II.
Chou CL; Sadegh-Nasseri S
J Exp Med; 2000 Dec; 192(12):1697-706. PubMed ID: 11120767
[TBL] [Abstract][Full Text] [Related]
18. Mediation by HLA-DM of dissociation of peptides from HLA-DR.
Sloan VS; Cameron P; Porter G; Gammon M; Amaya M; Mellins E; Zaller DM
Nature; 1995 Jun; 375(6534):802-6. PubMed ID: 7596415
[TBL] [Abstract][Full Text] [Related]
19. Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs.
van Ham SM; Grüneberg U; Malcherek G; Bröker I; Melms A; Trowsdale J
J Exp Med; 1996 Nov; 184(5):2019-24. PubMed ID: 8920889
[TBL] [Abstract][Full Text] [Related]
20. Conformational lability in the class II MHC 310 helix and adjacent extended strand dictate HLA-DM susceptibility and peptide exchange.
Painter CA; Negroni MP; Kellersberger KA; Zavala-Ruiz Z; Evans JE; Stern LJ
Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19329-34. PubMed ID: 22084083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
